Methotrexate Has No Antifibrotic Effect in Bleomycin-induced Experimental Scleroderma

dc.contributor.authorOzgen, Metin
dc.contributor.authorKoca, Suleyman S.
dc.contributor.authorIsik, Ahmet
dc.contributor.authorOzercan, Ibrahim H.
dc.date.accessioned2026-08-12T17:30:25Z
dc.date.issued2010
dc.departmentFırat Üniversitesi
dc.description.abstract[Abstract Not Available]
dc.identifier.doi10.3899/jrheum.090961
dc.identifier.endpage680
dc.identifier.issn0315-162X
dc.identifier.issn1499-2752
dc.identifier.issue3
dc.identifier.orcid0000-0003-4995-430X
dc.identifier.pmid20197571
dc.identifier.scopus2-s2.0-77949754964
dc.identifier.scopusqualityQ2
dc.identifier.startpage678
dc.identifier.urihttps://doi.org/10.3899/jrheum.090961
dc.identifier.urihttps://hdl.handle.net/11508/56092
dc.identifier.volume37
dc.identifier.wosWOS:000275135700042
dc.identifier.wosqualityQ2
dc.indekslendigikaynakWeb of Science
dc.indekslendigikaynakScopus
dc.indekslendigikaynakPubMed
dc.language.isoen
dc.publisherJ Rheumatol Publ Co
dc.relation.ispartofJournal of Rheumatology
dc.relation.publicationcategoryDiğer
dc.rightsinfo:eu-repo/semantics/openAccess
dc.snmzKA_WoS_20260511
dc.subjectModel
dc.subjectFibroblasts
dc.subjectPlacebo
dc.subjectTrial
dc.titleMethotrexate Has No Antifibrotic Effect in Bleomycin-induced Experimental Scleroderma
dc.typeLetter

Dosyalar